Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.
Símbolo de cotizaciónXTNT
Nombre de la empresaXtant Medical Holdings Inc
Fecha de salida a bolsaJun 30, 2010
Director ejecutivoMr. Sean E. Browne
Número de empleados217
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 30
Dirección664 Cruiser Lane
CiudadBELGRADE
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal59714
Teléfono14063880480
Sitio Webhttps://xtantmedical.com/
Símbolo de cotizaciónXTNT
Fecha de salida a bolsaJun 30, 2010
Director ejecutivoMr. Sean E. Browne
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos